Cite
Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemia.
MLA
Radujkovic, Aleksandar, et al. “Imatinib-Supplemented Myeloablative Total-Body Irradiation/Cyclophosphamide Conditioning Prior to Allogeneic Stem Cell Transplantation as Consolidation Treatment in Patients with Blast Crisis of Chronic Myeloid Leukemia.” European Journal of Haematology, vol. 92, no. 6, June 2014, pp. 546–49. EBSCOhost, https://doi.org/10.1111/ejh.12289.
APA
Radujkovic, A., Dreger, P., Hegenbart, U., Buss, E. C., Luft, T., Ho, A. D., Fruehauf, S., & Topaly, J. (2014). Imatinib-supplemented myeloablative total-body irradiation/cyclophosphamide conditioning prior to allogeneic stem cell transplantation as consolidation treatment in patients with blast crisis of chronic myeloid leukemia. European Journal of Haematology, 92(6), 546–549. https://doi.org/10.1111/ejh.12289
Chicago
Radujkovic, Aleksandar, Peter Dreger, Ute Hegenbart, Eike C. Buss, Thomas Luft, Anthony D. Ho, Stefan Fruehauf, and Julian Topaly. 2014. “Imatinib-Supplemented Myeloablative Total-Body Irradiation/Cyclophosphamide Conditioning Prior to Allogeneic Stem Cell Transplantation as Consolidation Treatment in Patients with Blast Crisis of Chronic Myeloid Leukemia.” European Journal of Haematology 92 (6): 546–49. doi:10.1111/ejh.12289.